Shanghai Rongtai (China) Performance
| 603579 Stock | 14.30 0.15 1.04% |
On a scale of 0 to 100, Shanghai Rongtai holds a performance score of 9. The entity has a beta of -0.2, which indicates not very significant fluctuations relative to the market. As returns on the market increase, returns on owning Shanghai Rongtai are expected to decrease at a much lower rate. During the bear market, Shanghai Rongtai is likely to outperform the market. Please check Shanghai Rongtai's downside deviation, standard deviation, and the relationship between the semi deviation and coefficient of variation , to make a quick decision on whether Shanghai Rongtai's existing price patterns will revert.
Risk-Adjusted Performance
9 of 100
Weak | Strong |
OK
Compared to the overall equity markets, risk-adjusted returns on investments in Shanghai Rongtai Health are ranked lower than 9 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Shanghai Rongtai sustained solid returns over the last few months and may actually be approaching a breakup point. ...more
Payout Ratio 0.9427 | Last Split Factor 1.3:1 | Ex Dividend Date 2024-10-16 | Last Split Date 2024-06-05 |
| Begin Period Cash Flow | 1.3 B |
Shanghai |
Shanghai Rongtai Relative Risk vs. Return Landscape
If you would invest 1,205 in Shanghai Rongtai Health on August 29, 2024 and sell it today you would earn a total of 225.00 from holding Shanghai Rongtai Health or generate 18.67% return on investment over 90 days. Shanghai Rongtai Health is generating 0.3299% of daily returns and assumes 2.6345% volatility on return distribution over the 90 days horizon. Simply put, 23% of stocks are less volatile than Shanghai, and 94% of all equity instruments are likely to generate higher returns than the company over the next 90 trading days. Expected Return |
| Risk |
Shanghai Rongtai Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Shanghai Rongtai's investment risk. Standard deviation is the most common way to measure market volatility of stocks, such as Shanghai Rongtai Health, and traders can use it to determine the average amount a Shanghai Rongtai's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.1252
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | ||||
| Small Returns | 603579 | |||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 2.63 actual daily | 23 77% of assets are more volatile |
Expected Return
| 0.33 actual daily | 6 94% of assets have higher returns |
Risk-Adjusted Return
| 0.13 actual daily | 9 91% of assets perform better |
Based on monthly moving average Shanghai Rongtai is performing at about 9% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Shanghai Rongtai by adding it to a well-diversified portfolio.
Shanghai Rongtai Fundamentals Growth
Shanghai Stock prices reflect investors' perceptions of the future prospects and financial health of Shanghai Rongtai, and Shanghai Rongtai fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Shanghai Stock performance.
| Return On Equity | 0.0981 | ||||
| Return On Asset | 0.0339 | ||||
| Profit Margin | 0.11 % | ||||
| Operating Margin | 0.11 % | ||||
| Current Valuation | 2.53 B | ||||
| Shares Outstanding | 177.38 M | ||||
| Price To Book | 1.31 X | ||||
| Price To Sales | 1.46 X | ||||
| Revenue | 1.86 B | ||||
| Gross Profit | 528.47 M | ||||
| EBITDA | 240.11 M | ||||
| Net Income | 202.71 M | ||||
| Total Debt | 129.13 M | ||||
| Book Value Per Share | 11.09 X | ||||
| Cash Flow From Operations | 344.29 M | ||||
| Earnings Per Share | 1.06 X | ||||
| Total Asset | 3.38 B | ||||
| Retained Earnings | 1.17 B | ||||
About Shanghai Rongtai Performance
By analyzing Shanghai Rongtai's fundamental ratios, stakeholders can gain valuable insights into Shanghai Rongtai's financial health, operational efficiency, and overall profitability, helping them make informed investment and management decisions. For instance, if Shanghai Rongtai has a high ROA and ROE, it suggests that the company is efficiently using its assets and equity to generate substantial profits, making it an attractive investment. Conversely, if Shanghai Rongtai has a low ROA and ROE, it may indicate underlying issues in asset and equity management, signaling a need for operational improvements.
Shanghai Rongtai is entity of China. It is traded as Stock on SHG exchange.Things to note about Shanghai Rongtai Health performance evaluation
Checking the ongoing alerts about Shanghai Rongtai for important developments is a great way to find new opportunities for your next move. Stock alerts and notifications screener for Shanghai Rongtai Health help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| About 56.0% of the company shares are owned by insiders or employees | |
| Latest headline from news.google.com: Discovering Undiscovered Gems In November 2024 - Yahoo Finance |
- Analyzing Shanghai Rongtai's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Shanghai Rongtai's stock is overvalued or undervalued compared to its peers.
- Examining Shanghai Rongtai's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Shanghai Rongtai's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Shanghai Rongtai's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Shanghai Rongtai's stock. These opinions can provide insight into Shanghai Rongtai's potential for growth and whether the stock is currently undervalued or overvalued.
Complementary Tools for Shanghai Stock analysis
When running Shanghai Rongtai's price analysis, check to measure Shanghai Rongtai's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy Shanghai Rongtai is operating at the current time. Most of Shanghai Rongtai's value examination focuses on studying past and present price action to predict the probability of Shanghai Rongtai's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move Shanghai Rongtai's price. Additionally, you may evaluate how the addition of Shanghai Rongtai to your portfolios can decrease your overall portfolio volatility.
| Price Exposure Probability Analyze equity upside and downside potential for a given time horizon across multiple markets | |
| Instant Ratings Determine any equity ratings based on digital recommendations. Macroaxis instant equity ratings are based on combination of fundamental analysis and risk-adjusted market performance | |
| Portfolio Diagnostics Use generated alerts and portfolio events aggregator to diagnose current holdings | |
| AI Portfolio Architect Use AI to generate optimal portfolios and find profitable investment opportunities |